Posts on RVNC

Latest ideas and analyses related to Revance Therapeutics Inc. Common Stock

You may also enter '* TRADES' to see all trade recommendations, '* QUESTIONS' to see all questions, and '* COMMENTS' to see all comments.
RVNC

+12 pts



Daxxify Positioned to Disrupt. Initiating Coverage at Buy. PT $33.

By ethonomics on Sept. 22, 2022, 5:03 p.m.
Tagged topics: initiation report

Views: 7, Votes: 3, Responses: 0, Attachments: 1
RVNC

+11 pts



Daxxify Approval Opens Up Major Avenue of Growth; Maintain Buy Rating and Raise PT to $30

By Thomasidea on Sept. 19, 2022, 10:24 a.m.
Tagged topics: healthcare

Views: 4, Votes: 2, Responses: 0, Attachments: 1
RVNC

+31 pts



Revance Therapeutics Inc. Fillers Franchise Continues to Evolve; While No News is Good News on DAXI Till Sep 8th

By Thomasidea on May 19, 2022, 1:36 a.m.
Tagged topics: US

Views: 15, Votes: 2, Responses: 0, Attachments: 1